Metabolic syndrome prevention

Rothwell PM (2005). Prevention of stroke in patients with diabetes mellitus and the metabolic syndrome. Cerebrovascular Diseases 1 24-34... 

Sattar N, Gaw A, Scherbakova O, Ford I, O Reilly DSJ, Haffner SM, et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003 108 414-419. 

Furthermore, a diet with low contents of FA may be involved in the development of insulin resistance, which suggests that an appropriate dietary intake of n-3 PUFA is considered protective against metabolic syndrome [183]. In addition, diverse psyquiatric impairs (depression, bipolar disorders, schizophrenia, autism) and neurodegenerative diseases such as Alzheimer disease have been associated to decreased blood levels of n-3 HUFA. Besides, there are many examples about the use of pol)nmsaturated FA as drugs. Thus, EPA has shown efficacy as adjunctive treatment, and in some cases as the only treatment in several psyquiatric disorders [184]. It is suggested that the potential of n-3 FA to prevent recurrence and metastasis of mammary cancer when used in adjuvant therapy is associated with a n-6 to n-3 ratio lower than 2 1 [185], On the other hand, fish intake is considered as a protective factor for preventing prostate cancer in addition, in humans low levels of ALA in mammary adipose tissue are associated with an increased risk of breast cancer in women [186]. 

Liu, L., Y. Wang, K. S. Lam, and A. Xu. Moderate Wine Consumption in the Prevention of Metabolic Syndrome and Its Related Medical Complications. Endocr Metab Immune Disord Drug Targets 8, no. 2 (June 2008) 89-98. 

James, P. T., N. Rigby and R. Leach (2004). The obesity epidemic, metabolic syndrome and future prevention strategies. Eur J Cardio-vasc Prev Rehabil 11(1) 3-8. 

CHD or CHD equivalents. Specific models for therapeutic life-style changes and drug therapy in the primary prevention of CHD have been recommended by ATP III (Figures 26-23 and 26-24). As for the management of patients with metabolic syndrome, a combination approach of weight reduction, increased physical activity, and appropriate control of lipid levels is recommended. 

Of the markers mentioned previously in this chapter, only hsCRP has fulfilled the required criteria for a novel marker of CHD risk, and national guideUnes for its measurement in the primary prevention of CHD have recently been issued jointly by the American Heart Association (AHA) and the CDC (AHAyCDC). Here we discuss the roles of hsCPR in CHD, the metabolic syndrome, diabetes, and hypertension, and its possible role in atherogenesis. We conclude with a discussion of possible preventive measures in those individuals with increased levels of hsCRP. A comprehensive review on this subject has been published. 

This report modifies earlier recommendations and provides a new way of risk-stratifying patients based on multiple risk factors and the presence of diabetes and the metabolic syndrome. The American Heart Association (AHA) also provides guidelines for primary and secondary prevention of CHD. ... 

Ikeda, I. Multifunctional effects of green tea catechins on prevention of the metabolic syndrome. Asia Pac J Clin Nutr 17 Suppl 1 273-274, 2008. 

Improvement in the insuhn resistance that under-hes the pathogenesis of type 2 diabetes and the metabolic syndrome leads to pleiotropic effects, including reduced glycemia, enhanced beta cell function, reduction in the inflammatory milieu, improvement in dyshpidemia and blood pressure vascular endothehal function, cardiovascular risk reduction, and in the prevention of diabetes. 

Keywords acarbose, pharmacology, diabetes, metabolic syndrome, primary prevention, cardiovascular... 

Tenenbaum A, Motro M, Fisman EZ, et al. Bezafibrate for the secondary prevention of myocardial infarction in patients with metabolic syndrome. Arch Intern Med. 2005 165 1154-1160. 

Ricci-Cabello, L, Olalla Herrera, M., Artacho, R. (2011). Possible role of milk-derived bioactive peptides in the treatment and prevention of metabolic syndrome. Nutrition Reviews, 70, 241-255. 

Numerous researchers have drawn attention to the beneficial properties that avocado could provide to human health. Some of these healthy benehts have been summarized in Figure 8.1. Wilson Grant, in 1960, published the hrst clinical study where avocado intake was associated with the maintenance of normal serum cholesterol levels, or even with their reduction [7]. Later on, in the 90s and beginning of 2000 there was an increase in the number of works that studied the relationship between avocado fat and its effect on cardiovascular diseases, cholesterol, lipid profile, weight control, and diabetes [8-16]. While the principal healthy benehts attributed to avocado fruit are the aforementioned, some others have also been evaluated, such as prevention and treatment of osteoarthritis [17,18], anticancer properties [19-24], protective activity against liver injury [25], skin protection [26-28], reduction of risk of macular degeneration [29], inhuence on short-term memory [30], antioxidant activity [31-37], reduction of metabolic syndrome risk [38,39], and anti-inhammatory effects [31,32,40]. 

---